A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine

Eur Psychiatry. 2004 Jun;19(4):233-4. doi: 10.1016/j.eurpsy.2003.07.015.

Abstract

A 25-year-old man with DSM-IV-TR Axis I social phobia and Axis II avoidant personality disorder and erectile dysfunction, presenting with depression, anxiety and insomnia, responded partially to extended release oral venlafaxine (75 mg/die for 6 weeks), but developed side effects and worsening symptoms when dose was increased to 150 mg/die; he responded to a combination of 75 mg/die venlafaxine and 4 mg/die reboxetine and improved on most of his symptoms.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cyclohexanols / therapeutic use*
  • Drug Therapy, Combination
  • Erectile Dysfunction / complications*
  • Erectile Dysfunction / drug therapy*
  • Humans
  • Male
  • Morpholines / therapeutic use*
  • Personality Disorders / complications*
  • Personality Disorders / drug therapy*
  • Personality Disorders / psychology
  • Phobic Disorders / complications*
  • Phobic Disorders / diagnosis
  • Phobic Disorders / psychology
  • Reboxetine
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Venlafaxine Hydrochloride

Substances

  • Cyclohexanols
  • Morpholines
  • Serotonin Uptake Inhibitors
  • Venlafaxine Hydrochloride
  • Reboxetine